|
1
|
Mekeel KL and Hemming AW: Surgical
management of gallbladder carcinoma: a review. J Gastrointest Surg.
11:1188–1193. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Miller G and Jarnagin WR: Gallbladder
carcinoma. Eur J Surg Oncol. 34:306–312. 2008. View Article : Google Scholar
|
|
3
|
Khdair A, Handa H, Mao G and Panyam J:
Nanoparticle-mediated combination chemotherapy and photodynamic
therapy overcomes tumor drug resistance in vitro. Eur J Pharm
Biopharm. 71:214–222. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schrader AJ, Seger M, Konrad L, et al:
Clinical impact of MDR1-expression in testicular germ cell cancer.
Exp Oncol. 29:212–216. 2007.PubMed/NCBI
|
|
5
|
Bark H, Xu HD, Kim SH, Yun J and Choi CH:
P-glycoprotein down-regulates expression of breast cancer
resistance protein in a drug-free state. FEBS Lett. 582:2595–2600.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Berger W, Setinek U, Hollaus P, et al:
Multidrug resistance markers P-glycoprotein, multidrug resistance
protein 1, and lung resistance protein in non-small cell lung
cancer: prognostic implications. J Cancer Res Clin Oncol.
131:355–363. 2005. View Article : Google Scholar
|
|
7
|
Bottke D, Koychev D, Busse A, et al:
Fractionated irradiation can induce functionally relevant multidrug
resistance gene and protein expression in human tumor cell lines.
Radiat Res. 170:41–48. 2008. View
Article : Google Scholar
|
|
8
|
Hanson JA, Gillespie JW, Grover A, et al:
Gene promoter methylation in prostate tumor-associated stromal
cells. J Natl Cancer Inst. 98:255–261. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pandey SN, Jain M, Nigam P, Choudhuri G
and Mittal B: Genetic polymorphisms in GSTM1, GSTT1, GSTP1, GSTM3
and the susceptibility to gallbladder cancer in North India.
Biomarkers. 11:250–261. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tiirikainen MI, Elonen E, Syrjälä MT,
Jansson SE and Krusius T: Flow cytometric analysis of
glutathione-S-transferase-pi in acute leukemia. Leukemia.
8:978–984. 1994.PubMed/NCBI
|
|
11
|
Somlo G, Chu P, Frankel P, et al:
Molecular profiling including epidermal growth factor receptor and
p21 expression in high-risk breast cancer patients as indicators of
outcome. Ann Oncol. 19:1853–1859. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Perry AS, Loftus B, Moroose R, et al: In
silico mining identifies IGFBP3 as a novel target of methylation in
prostate cancer. Br J Cancer. 96:1587–1594. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sutoh I, Kohno H, Nakashima Y, et al:
Concurrent expressions of metallothionein, glutathione
S-transferase-pi, and P-glycoprotein in colorectal cancers. Dis
Colon Rectum. 43:221–232. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nevin JE, Moran TJ, Kay S and King R:
Carcinoma of the gallbladder: staging, treatment, and prognosis.
Cancer. 37:141–148. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Henson DE, Albores-Saavedra J and Corle D:
Carcinoma of the gallbladder. Histologic types, stage of disease,
grade, and survival rates. Cancer. 70:1493–1497. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Levy AD, Murakata LA and Rohrmann CA Jr:
Gallbladder Carcinoma: radiologic-pathologic correlation.
Radiographics. 21:295–314. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gottesman MM and Pastan I: The multidrug
transporter, a double-edged sword. J Biol Chem. 263:12163–12166.
1988.PubMed/NCBI
|
|
18
|
Rodriguez C, Commes T, Robert J and Rossi
JF: Expression of P-glycoprotein and anionic glutathione
S-transferase genes in non-Hodgkin’s lymphoma. Leuk Res.
17:149–154. 1993.PubMed/NCBI
|
|
19
|
Kufe DW, Pollock RE, Weichselbaum RR, et
al: Holland-Frei Cancer Medicine. 6th edition. Hamilton (ON): BC
Decker; pp. 711–726. 2003
|
|
20
|
Stewart DJ: Mechanisms of resistance to
cisplatin and carboplatin. Crit Rev Oncol Hematol. 63:12–31. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen YK and Lin LM: Placental glutathione
S-transferase isoenzyme expression in polycyclic aromatic
hydrocarbon-induced hemster buccal pouch mucosa. Oral Oncol.
34:180–185. 1998. View Article : Google Scholar
|
|
22
|
Tsuchida S and Sato K: Glutathione
transferses and cancer. Crit Rev Biochem Mol Biol. 27:337–384.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Takabayashi A, Watkins JB, Soloway RD,
Rios-Dalenz J and Henson DE: Glycolithocolic acid is greatly
increased in stones from patients with carcinoma of the
gallbladder. Gastroenterology. 79:1058–1063. 1980.
|
|
24
|
Henson DE, Albores-Saavedra J and Corle D:
Carcinoma of the gallbladder. Histologic types, stage of disease,
grade, and survival rates. Cancer. 70:1493–1497. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lazcano-Ponce EC, Miquel JF, Muñoz N, et
al: Epidemiology and molecular pathology of gallbladder cancer. CA
Cancer J Clin. 51:349–364. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Seo S, Hatano E, Higashi T, et al:
Fluorine-18 fluorodeoxyglucose positron emission tomography
predicts tumor differentiation, P-glycoprotein expression, and
outcome after resection in hepatocellular carcinoma. Clin Cancer
Res. 13:427–433. 2007. View Article : Google Scholar
|
|
27
|
Sinicrope FA, Hart J, Brasitus TA,
Michelassi F, Lee JJ and Safa AR: Relationship of P-glycoprotein
and carcinoenbryonic antigen expression in human colon carcinoma to
local invision, DNA ploidy, and disease relapse. Cancer.
74:2908–2907. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Saint-Ruf C, Malfoy B, Scholl S, Zafrani B
and Dutrillaux B: GST gene is frequently complified with INT2 and
HSTF1 proto-oncogene in human breast cancers. Oncogene. 16:403–406.
1991.PubMed/NCBI
|
|
29
|
Slebos RJ, Kibbelaar RE, Dalesio O, et al:
K-ras oncogene activation as a prognostic marker in adenocarcinomar
of the lung. N Eng J Med. 323:561–565. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tsuda H, Hirohashi S, Shimosato Y, et al:
Correlation between long-term survival in breast cancer patients
and amplification of two putive oncogene-coamplification units:
hst-1/int-2 and c-erbB-2/ear-1. Cancer Res. 49:3104–3108.
1989.PubMed/NCBI
|
|
31
|
Charpin C, Vielh P, Duffaud F, et al:
Quantitative immunocytochemical assays of P-glycoprotein in breast
carcinoma: correlation to messanger RNA experession and to
immunohistochemical prognostic indicators. J Natl Cancer Inst.
86:1539–1545. 1994. View Article : Google Scholar
|
|
32
|
Ralhan R, Swain RK, Agarwal S, et al:
P-glycoprotein is positively correlated with p53 in human oral
pre-malignant and malignant lesions and is associated with poor
prognosis. Int J Cancer. 84:80–85. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Malik IA: Gallbladder cancer: current
status. Expert Opin Pharmacother. 5:1271–1277. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Brotherick I, Shenton BK, Egan M, et al:
Examination of multidrug resistance in cell lines and primary
breast tumours by flow cytometry. Eur J Cancer. 32A:2334–2341.
1996. View Article : Google Scholar : PubMed/NCBI
|
